|
|
||||||||
Journal of Applied Physiology, Vol 69, Issue 3 875-879, Copyright © 1990 by American Physiological Society
ARTICLES |
W. H. Stevens, P. J. Manning, R. M. Watson and P. M. O'Byrne
Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Methacholine inhalation tests measure airway responsiveness in asthmatic and normal subjects. Tachyphylaxis occurs with repeated methacholine inhalations in normal subjects. The purpose of this study was to examine the time course and mechanisms of methacholine tachyphylaxis in normal subjects and to determine whether this occurs in mildly asthmatic subjects. Fifteen normal and nine asthmatic subjects were studied on 2 study days, at least 48 h apart. Each day, two inhalation tests were carried out. On one day, subjects performed two methacholine inhalation tests 3 h later by a methacholine test. Results were expressed as the provocation concentration causing a 20% fall in forced expiratory volume in 1 s (FEV1), (PC20). All normal subjects developed methacholine tachyphylaxis. The mean PC20 increased from 47.3 mg/ml (%SE 1.34) to 115.6 (%SE 1.51) (P less than 0.0001) in a 3-h interval. This increase lasted for greater than or equal to 6 h (P = 0.012). Asthmatic subjects did not develop methacholine tachyphylaxis. Their mean methacholine PC20s were 1.6 mg/ml (%SE 1.4) and 1.5 (%SE 1.4) (P = 0.75) 3 h later. In two other series of experiments, normal subjects were pretreated with the cyclooxygenase inhibitors indomethacin (100 mg/day) or flurbiprofen (150 mg/day) or a placebo for 3 days before two methacholine tests 3 h apart. Both indomethacin and flurbiprofen significantly inhibited the development of methacholine tachyphylaxis. These results confirm that methacholine tachyphylaxis occurs in normal subjects, lasts greater than or equal to 6 h, and may occur through the release of inhibitory prostaglandins. By contrast, methacholine tachyphylaxis does not occur in asthmatic subjects.
This article has been cited by other articles:
![]() |
L.-Y. Wang, F. J. Cerny, T. J. Kufel, and B. J. B. Grant Simulated obesity-related changes in lung volume increases airway responsiveness in lean, nonasthmatic subjects. Chest, September 1, 2006; 130(3): 834 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Cockcroft and B. E. Davis Lack of Tachyphylaxis to Methacholine at 24 h Chest, September 1, 2005; 128(3): 1248 - 1251. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. DEROM, L. BORGSTROM, J. VAN SCHOOR, A.-B. LOFROOS, and R. PAUWELS Lung Deposition and Protective Effect of Terbutaline Delivered from Pressurized Metered-Dose Inhalers and the Turbuhaler in Asthmatic Individuals Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1398 - 1402. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Crapo Guidelines for Methacholine and Exercise Challenge Testing---1999 . THIS OFFICIAL STATEMENT OF THE AMERICAN THORACIC SOCIETY WAS ADOPTED BY THE ATS BOARD OF DIRECTORS, JULY 1999 Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 309 - 329. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |